Medical Advisory Firms Move Earlier in Healthcare Decision Cycles

A treatment plan may rely on clinical expertise; however, a considerable number of decisions in the healthcare industry are now made well before reaching a patient. Program design, evidence, and implementation require hospitals, life sciences companies and healthcare organizations to make complicated decisions. Therefore, the use of medical consulting and advisory services has been extended to decision-making phases.

When new healthcare programs are designed, medical advisory firms often get involved in evaluating the evidence and clinical pathway in order to make sure that all available facts are considered. In addition, a lack of data may prevent making a recommendation. It is helpful, especially for healthcare organizations that work with limited resources or apply a novel clinical approach.

Unlike management consulting, advice provided by medical advisory firms is based on clinical practice and scientific evidence. Medical advisory teams are often able to consider a clinical pathway along with processes in a hospital or organization.

Furthermore, healthcare organizations are under great pressure to justify their clinical decisions. When taking certain actions, healthcare professionals need not only published data but also the feasibility and local needs of care, instead of general assumptions. Hence, the use of advisory services is a way to evaluate these issues before a major investment.

In addition, life sciences companies that prepare to enter the market often experience similar problems. There may be sufficient scientific information about a product; however, in order to provide healthcare professionals with a guide, it is necessary to interpret scientific findings. In most cases, medical advisory firms help to format communication so that a conversation will stay evidence-based.

Therefore, the increased involvement of advisory specialists is caused by the growing complexity of healthcare decisions. There may be several factors, including new therapy options, changes in clinical standards and environment, and so on. Hence, when advising an organization, it is necessary not only to interpret clinical evidence but also to consider implementation aspects.

Advisory work has become more interactive. Instead of developing recommendations on their own, consultants usually work together with physicians, researchers and the internal healthcare team during the planning process. Thus, a question can be raised during early phases of the process in order to avoid complications at later stages.

Buyers of medical advisory services pay more attention to the quality of clinical reasoning than to the amount of supporting documents. However, detailed reports are still very important. Currently, healthcare organizations need advice explaining the reasons behind a recommendation and possible areas of uncertainty.

Medical consulting cannot replace the internal clinical expertise of healthcare organizations. However, its increased role shows that many organizations are interested in clinical advice at the early stage of decision-making.